What does CUSIP 10501E201 represent in this 13F holders report?

CUSIP 10501E201 is the security identifier for BCLI - BRAINSTORM CELL THERAPEUTICS - COM NEW used to aggregate holder disclosures.

How many institutions held BCLI - BRAINSTORM CELL THERAPEUTICS - COM NEW in Q1 2019?

37 institutional investors reported BCLI - BRAINSTORM CELL THERAPEUTICS - COM NEW for Q1 2019. Use the holders table for investor-level position and value details.

BRAINSTORM CELL THERAPEUTICS - COM NEW (BCLI)

CUSIP: 10501E201

Q1 2019 13F Holders as of 31 Mar 2019

Security type / class: Equity / COM NEW
Total 13F shares: 2,412,638
Total 13F value: $10,468,445
Share change: -37,334
Put/Call ratio: 964%
SEC-reported price per share: $4.34
Number of holders: 37
Value change: -$161,185
Number of buys: 17
Number of sells: 6

Security key

10501E201

Report period

Q1 2019

Institutions

Top holders

BCLI full security history Ownership snapshot Full 13F holder table BRAINSTORM CELL THERAPEUTICS INC. SEC filings BRAINSTORM CELL THERAPEUTICS INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of BCLI - BRAINSTORM CELL THERAPEUTICS - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

SABBY MANAGEMENT, LLC

Disclosed value leader

SABBY MANAGEMENT, LLC

Comparable rows

0/15

Latest evidence

31 Dec 2018

13F Highest disclosed value: $3,588,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

SABBY MANAGEMENT, LLC has the largest disclosed position value at $3.59M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens SABBY MANAGEMENT, LLC's linked filing trail.

Disclosed position value Top 5

SABBY MANAGEMENT, LLC $3.59M

VANGUARD GROUP INC $2.44M

RENAISSANCE TECHNOLOGIES LLC $648K

GEODE CAPITAL MANAGEMENT, LLC $373K

BlackRock Finance, Inc. $303K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
SABBY MANAGEMENT, LLC	13F Company 13F	— class O/S missing	$3,588,000 1,010,682 shares	—	31 Dec 2018
VANGUARD GROUP INC	13F Company 13F	— class O/S missing	$2,437,000 686,606 shares	—	31 Dec 2018
RENAISSANCE TECHNOLOGIES LLC	13F Company 13F	— class O/S missing	$648,000 182,457 shares	—	31 Dec 2018
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	— class O/S missing	$373,000 105,273 shares	—	31 Dec 2018
BlackRock Finance, Inc.	13F Company 13F	— class O/S missing	$303,000 85,294 shares	—	31 Dec 2018
ETF MANAGERS GROUP, LLC	13F Company 13F	— class O/S missing	$237,000 66,797 shares	—	31 Dec 2018

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2019

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

2,412,638

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2019 vs Q1 2019 Across Filers

Q1 2019 holders

Holder diff

Investor	Q1 2019 Shares	Q1 2019 Shares	Share Diff	Share Chg %	Q1 2019 value	Q1 2019 value	Value change	Value Chg %